After graduating with a BSc in Genetics from the University of Edinburgh, Dr. Ruman Rahman completed a PhD in Molecular Biology at the Roslin Institute, University of Edinburgh. He joined the Children’s Brain Tumour Research Centre, University of Nottingham, as a Post-Doctoral Research Associate in 2007.
After receiving the Nottingham Advanced Research Fellowship for the Faculty of Medicine in 2011, Dr. Rahman was appointed Assistant Professor in October 2013 and awarded the British Neuro-Oncology Society Young Investigator of the Year in 2014. He is currently an Associate Professor of Molecular Neuro-Oncology at the University of Nottingham’s new Biodiscovery Institute.
His research team focuses on intra-tumour transcriptomic and metabolomic heterogeneity for childhood and adult brain cancers, with a particular emphasis on infiltrative disease. As a direct corollary and the focus of this work, he has developed biomaterial-based drug delivery systems to target brain tumour infiltration when locally applied post-surgery.
Ruman Rahman is the Chair of the international Children's Brain Tumour Drug Delivery Consortium and co-Chair of the British Neuro-Oncology Society Research Subcommittee.
Short Biography
After graduating with a BSc in Genetics from the University of Edinburgh, Dr. Ruman Rahman completed a PhD in Molecular Biology at the Roslin Institute, University of Edinburgh. He joined the Children’s Brain Tumour Research Centre, University of Nottingham, as a Post-Doctoral Research Associate in 2007.
After receiving the Nottingham Advanced Research Fellowship for the Faculty of Medicine in 2011, Dr. Rahman was appointed Assistant Professor in October 2013 and awarded the British Neuro-Oncology Society Young Investigator of the Year in 2014. He is currently an Associate Professor of Molecular Neuro-Oncology at the University of Nottingham’s new Biodiscovery Institute.
His research team focuses on intra-tumour transcriptomic and metabolomic heterogeneity for childhood and adult brain cancers, with a particular emphasis on infiltrative disease. As a direct corollary and the focus of this work, he has developed biomaterial-based drug delivery systems to target brain tumour infiltration when locally applied post-surgery.
Ruman Rahman is the Chair of the international Children's Brain Tumour Drug Delivery Consortium and co-Chair of the British Neuro-Oncology Society Research Subcommittee.
Advance your academic career, collaborate globally, and expand your network—
join now
!
Well done!
